National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody G250
A chimeric monoclonal antibody directed against G250, a cell surface antigen found in the majority of renal cell carcinomas. Following binding, monoclonal antibody G250 (mAb G250) may be internalized by G250 antigen-expressing renal carcinoma cells; mAb G250 may be useful as a carrier for radioisotopes and other antineoplastic therapeutic agents. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:chimeric monoclonal antibody cG250
WX-G250
US brand name:Rencarex
Abbreviations:cG250
MOAB G250



Previous:monoclonal antibody CAL, monoclonal antibody CC49, monoclonal antibody CC49-delta CH2, monoclonal antibody Ch14.18, monoclonal antibody E2.3
Next:monoclonal antibody GD2 anti-idiotype vaccine, monoclonal antibody hA20, monoclonal antibody HeFi-1, monoclonal antibody hLL1, monoclonal antibody Hu3S193

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov